AeroSafe Global

Overview

AeroSafe Global is a Cold Chain as a Service (CCaaS) operator for temperature-sensitive biopharma shipments. Its core offer is a rental-based reusable packaging program: passive parcel shippers are conditioned, deployed, tracked, recovered, cleaned, and reused through a managed service rather than sold as one-time packaging.

AeroSafe is a reusable-packaging service vendor, not a 3PL, distributor, active-container manufacturer, or single-use shipper supplier. It is most relevant when product integrity, validated thermal performance, return logistics, and measurable reuse economics matter as much as the physical shipper. Compare AeroSafe against other reusable parcel-rental peers (Pelican BioThermal Crēdo on Demand), active-container providers (CSafe, Va-Q-tec, Sonoco ThermoSafe rental), and embedded specialty distributor packaging programs.

Cold Chain and Packaging Capability Model

The framework below standardizes how Rx Almanac evaluates packaging-contract-manufacturing capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, AeroSafe Global is evaluated as a Cold Chain as a Service (CCaaS) operator for temperature-sensitive biopharma shipments.

Capability	Buyer should compare	AeroSafe Global readout
Temperature range and packaging formats	Ambient, CRT, 2-8C, frozen, ultra-cold, cryogenic, parcel, pallet, active, and passive configurations.	Core packaging system. AeroSafe is strongest in reusable passive parcel shipping for temperature-sensitive medicines.
Qualification, validation, and lane design	ISTA/GDP qualification, thermal modeling, lane profiles, SOPs, stability assumptions, and validation documentation.	Validate by lane. Buyers should request product-specific qualification packages, lane profiles, and duration assumptions rather than rely on generic performance claims.
Reusable, rental, and sustainability model	Reusable shipper programs, rental pools, reverse logistics, waste reduction, carbon reporting, and cost per use.	Core reuse model. The CCaaS model depends on rental economics, high recovery, cleaning / refurbishment, and measurable reuse.
Monitoring, sensors, and excursion response	Temperature indicators, IoT sensors, real-time tracking, excursion triage, and quality documentation.	Core monitoring layer. Cold Chain Intel is positioned for delivery visibility and temperature verification.
Global logistics support and availability	Manufacturing footprint, inventory availability, international compliance, distribution partners, and launch surge reliability.	Diligence required. Confirm service-center coverage, inventory commitments, carrier handoffs, and return-flow timing for the launch footprint.
Specialty, biologic, and CGT readiness	Suitability for high-value biologics, cell/gene therapies, clinical supply, specialty pharmacy, or direct-to-patient shipments.	Documented fit. The public partner set points to specialty pharmaceutical distribution and temperature-sensitive commercial products.

Buyer Fit

• When it belongs in the set: Include AeroSafe when the manufacturer wants a managed reusable parcel-shipping program rather than simply buying qualified boxes.
• Therapy and product fit: Best fit is high-value temperature-sensitive specialty, biologic, and provider-administered products where a failed lane is expensive and sustainability reporting matters.
• Commercial fit: Pricing is Custom/RFP, so assume an RFP-led scope with service levels, data feeds, launch timing, and governance defined in the statement of work.
• Operating fit: AeroSafe can sit beside a specialty distributor, specialty pharmacy, 3PL, or manufacturer logistics team; define who owns carrier selection, temperature monitoring, exception handling, and product disposition.
• Award diligence: Confirm lane-level qualification evidence, excursion protocols, inventory availability, recovery SLAs, sustainability baselines, and data feeds into the manufacturer’s quality system.

Differentiators

• Reusable service model: AeroSafe is positioned around a managed rental program, so the value proposition includes packaging assets, conditioning, tracking, recovery, cleaning, and reuse.
• Passive parcel specialization: The offer is particularly relevant to parcel lanes where high-performance insulation can avoid active mechanical cooling.
• Cold Chain Intel: The visibility platform gives buyers a way to monitor shipment status and temperature verification instead of treating packaging as a disconnected physical input.
• Circular-supply-chain economics: AeroSafe’s company materials emphasize that recovery and reuse rates drive both environmental and cost-per-use outcomes.
• Public partner proof points: BioCare announced a reusable temperature-controlled shipping partnership with AeroSafe in 2024, and Morris & Dickson referenced AeroSafe capabilities in its 2025 national distribution expansion.

RFP Questions

• Which exact temperature profiles, durations, package sizes, and lane conditions have been qualified for similar products?
• What happens operationally when a temperature excursion occurs, and who owns disposition documentation?
• How much shipper inventory, rental capacity, conditioning capacity, and service-center throughput is contractually reserved for launch?
• What recovery-rate SLA applies, and what happens economically if return flows fall below plan?
• Which data fields are available from Cold Chain Intel, and can they feed the manufacturer’s quality, supply-chain, or serialization systems?
• What sustainability baseline is being used for carbon, landfill, water, and energy comparisons?
• Which responsibilities does AeroSafe’s responsibility end if the carrier, distributor, hub, specialty pharmacy, or provider site causes an exception?

Recent Activity

• 2026-05 - Current AeroSafe materials emphasize integrated delivery-services positioning, point-of-care delivery, Delivery Intelligence / TRIP, 4+ day protection, and company-reported recovery / country metrics.

• April 2025: Morris & Dickson announced nationwide distribution licensing and cited AeroSafe capabilities for product tracking, product integrity, and environmental efficiency.

• November 2024: AeroSafe published a LogiPharma US recap describing Cold Chain Intel, reusable packaging lessons, and customer supply-chain executive participation.

• October 2024: BioCare announced a partnership with AeroSafe for reusable temperature-controlled shipping of temperature-sensitive products.

• August 2023: AeroSafe announced a $43 million financing round to support growth of its cold-chain service model.